Global Initiative for Asthma 2016–derived asthma control with fluticasone propionate and salmeterol

[1]  J. Rejas,et al.  Self-perceived Sleep Quality and Quantity in Adults With Asthma: Findings From the CosteAsma Study. , 2016, Journal of investigational allergology & clinical immunology.

[2]  Helen K. Reddel,et al.  A summary of the new GINA strategy: a roadmap to asthma control , 2015, European Respiratory Journal.

[3]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[4]  E. Bleecker,et al.  Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. , 2012, The Journal of allergy and clinical immunology.

[5]  H. Ortega,et al.  Low-dose fluticasone propionate with and without salmeterol in steroid-naïve patients with mild, uncontrolled asthma. , 2010, Respiratory medicine.

[6]  W. Busse,et al.  Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study , 2008, Allergy.

[7]  M. Hasselgren,et al.  Factors related to the level of severity of asthma in primary care. , 2007, Respiratory medicine.

[8]  M. Gould,et al.  Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. , 2007, The Journal of allergy and clinical immunology.

[9]  A. Woodcock,et al.  Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone. , 2007, Primary care respiratory journal : journal of the General Practice Airways Group.

[10]  E. Koshak.  Classification of asthma according to revised 2006 GINA: Evolution from severity to control , 2007, Annals of thoracic medicine.

[11]  W. Busse,et al.  The correlation between asthma control and health status: the GOAL study , 2006, European Respiratory Journal.

[12]  R. Pauwels,et al.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.

[13]  M. Kavuru,et al.  Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. , 2000, The Journal of allergy and clinical immunology.

[14]  W. Lumry,et al.  Combined Salmeterol 50 μ g and Fluticasone Propionate 250 μ g in the Diskus Device for the Treatment of Asthma , 2000 .